DetailsChartProfileRisk matrixNewsDocuments

Candriam Equities L Biotechnology, V - Capitalisation/  LU0317020203  /

Fonds
NAV1/14/2025 Chg.-34.8900 Type of yield Investment Focus Investment company
2,022.1100USD -1.70% reinvestment Equity Candriam ▶
     
Chart for Candriam Equities L Biotechnology, V - Capitalisation
  Name   ISIN Performance Volatility Sharpe ratio
1. Polar Capital Funds plc - Biotechnology Fund Class I EUR Distribution Shares IE00B3WVRB16 +13.82% 19.67% 0.57
2. Bellevue Funds (Lux) - Bellevue Obesity Solutions I2 EUR - Accumulating LU1725387622 +7.29% 10.76% 0.43
3. Bellevue Funds (Lux) - Bellevue Obesity Solutions I EUR - Accumulating LU0415392678 +7.14% 10.76% 0.41
4. Bellevue Funds (Lux) - Bellevue Obesity Solutions B EUR - Accumulating LU0415392249 +6.40% 10.77% 0.34
5. Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating LU0415392835 +6.67% 11.63% 0.34
6. Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating LU0415392595 +5.93% 11.63% 0.28
7. Mirova Biodiversity Equity Z-NPF/A (EUR) LU2636738325 +5.60% 10.83% 0.26
8. Bellevue Biotech DT CHF CH0113817123 +7.28% 18.37% 0.25
9. Candriam Equities L Biotech.R EUR Acc LU1269736838 +3.94% 17.93% 0.07
10. Bellevue Funds (Lux) - Bellevue Obesity Solutions I GBP - Accumulating LU0767968745 +4.89% 10.25% 0.21
...
38. Candriam Equities L Biotechnology, V - Capitalisation LU0317020203 -1.86% 17.19% -0.27